ATE112664T1 - Nadh und nadph als energiesubstitute. - Google Patents

Nadh und nadph als energiesubstitute.

Info

Publication number
ATE112664T1
ATE112664T1 AT92250002T AT92250002T ATE112664T1 AT E112664 T1 ATE112664 T1 AT E112664T1 AT 92250002 T AT92250002 T AT 92250002T AT 92250002 T AT92250002 T AT 92250002T AT E112664 T1 ATE112664 T1 AT E112664T1
Authority
AT
Austria
Prior art keywords
nadh
nadph
reduced form
adenine dinucleotide
nicotinamide adenine
Prior art date
Application number
AT92250002T
Other languages
German (de)
English (en)
Inventor
Joerg Univ-Prof Ddr Birkmayer
Walter Prof Dr Birkmayer
Original Assignee
Birkmayer Joerg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birkmayer Joerg filed Critical Birkmayer Joerg
Application granted granted Critical
Publication of ATE112664T1 publication Critical patent/ATE112664T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92250002T 1991-01-24 1992-01-06 Nadh und nadph als energiesubstitute. ATE112664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (cg-RX-API-DMAC7.html) 1991-01-24 1991-01-24

Publications (1)

Publication Number Publication Date
ATE112664T1 true ATE112664T1 (de) 1994-10-15

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92250002T ATE112664T1 (de) 1991-01-24 1992-01-06 Nadh und nadph als energiesubstitute.

Country Status (14)

Country Link
EP (1) EP0496479B1 (cg-RX-API-DMAC7.html)
JP (1) JP2533709B2 (cg-RX-API-DMAC7.html)
AT (1) ATE112664T1 (cg-RX-API-DMAC7.html)
AU (1) AU663479B2 (cg-RX-API-DMAC7.html)
BR (1) BR9200207A (cg-RX-API-DMAC7.html)
CA (1) CA2059510C (cg-RX-API-DMAC7.html)
DE (2) DE4102240C1 (cg-RX-API-DMAC7.html)
DK (1) DK0496479T3 (cg-RX-API-DMAC7.html)
ES (1) ES2061313T3 (cg-RX-API-DMAC7.html)
FI (1) FI920323A7 (cg-RX-API-DMAC7.html)
HU (1) HU9200213D0 (cg-RX-API-DMAC7.html)
IE (1) IE69861B1 (cg-RX-API-DMAC7.html)
NO (1) NO304672B1 (cg-RX-API-DMAC7.html)
ZA (1) ZA92275B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
IT1318565B1 (it) * 2000-06-09 2003-08-27 World Pharma Tech Ltd Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (de) * 2008-02-20 2011-02-10 Emag Holding Gmbh Verfahren zum Schleifen wellenförmiger Werkstücke
DE102014103443A1 (de) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit
WO2020021734A1 (ja) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 機能性鶏卵及びその生産方法
DE202022000567U1 (de) 2022-03-06 2022-03-16 Penta Phi Eg Liposomale Formulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
EP0331620B1 (de) * 1988-03-01 1993-08-11 Birkmayer, Walther, Prof. Dr. Mittel zur Behandlung des Parkinson-Syndroms
AT397201B (de) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
FI920323L (fi) 1992-07-25
NO920315L (no) 1992-07-27
JPH05262652A (ja) 1993-10-12
ZA92275B (en) 1992-12-30
NO304672B1 (no) 1999-02-01
DK0496479T3 (da) 1995-04-18
IE920198A1 (en) 1992-07-29
JP2533709B2 (ja) 1996-09-11
ES2061313T3 (es) 1994-12-01
IE69861B1 (en) 1996-10-16
CA2059510A1 (en) 1992-07-25
DE4102240C1 (cg-RX-API-DMAC7.html) 1992-04-09
EP0496479A1 (de) 1992-07-29
AU1039292A (en) 1992-07-30
FI920323A7 (fi) 1992-07-25
FI920323A0 (fi) 1992-01-24
HU9200213D0 (en) 1992-04-28
AU663479B2 (en) 1995-10-12
DE59200603D1 (de) 1994-11-17
BR9200207A (pt) 1992-10-06
NO920315D0 (no) 1992-01-23
CA2059510C (en) 1997-06-10
EP0496479B1 (de) 1994-10-12

Similar Documents

Publication Publication Date Title
ES2079173T3 (es) Formulacion para tratar ensilaje.
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
CA2054358A1 (en) High acid nutritional formulations
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
FI921183A0 (fi) Nya bensofusionerade laktamer, som fraemjar frigivning av tillvaexthormon.
ES2054697T3 (es) Un producto higienico, particularmente para la conservacion de la dentadura de un perro.
DZ1736A1 (fr) Spiro pipéridines et homologues qui favorisent la libération de l'hormone de croissance.
AU6417986A (en) Imidazo(15-a)quinoxaline derivatives and their preparation and use
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ATE112664T1 (de) Nadh und nadph als energiesubstitute.
FI862863A0 (fi) Foerfarande foer bindning av mikroflora och preparat foer detsamma.
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
DZ1735A1 (fr) Spiro pipéridines et homologues favorisant la libération de l'hormone de croissande.
NZ240011A (en) Oil-in-water emulsion nutritional composition: processes for production
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
MX9306049A (es) Dinucleotido de nicotinamida-ademina y fosfato de dinucleotido de nicotinamida-adenina como farmacos para tratar la enfermedad de alzheimer.
ATE86489T1 (de) Hilfsmittelfreie riboflavingranulate.
MY106830A (en) Preparation of a cooked product having an improved preservation based on animal proteins.
ES553196A0 (es) Procedimiento para la obtencion del acido propionico, sal amonica (2:1), y productos derivados utilizables en la conservacion de alimentos para consumo humano y animal
SU1575333A1 (ru) Стартовый корм для карпа
NO179602C (no) Anvendelse av et NADH eller NADPH ved fremstilling av et antidepresjonsmiddel
GB2016900A (en) Concentrated food product
Riopel et al. Coronary risk factor modification in children: smoking. A statement for physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association
EP0539516A4 (cg-RX-API-DMAC7.html)
GB9009446D0 (en) Veterinary composition

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee